Ganjali Shiva, Keshavarz Reihaneh, Hosseini Susan, Mansouri Atena, Mannarino Massimo R, Pirro Matteo, Jamialahmadi Tannaz, Sahebkar Amirhossein
Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Department of Genetics, Faculty of Biological Sciences, Tehran North Branch, Islamic Azad University, Tehran 1651153311, Iran.
J Clin Med. 2021 Dec 14;10(24):5867. doi: 10.3390/jcm10245867.
BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterizied by elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) which is an important source of substrates to be oxidized by different oxidative agents. Subsequently, the oxidized LDLs (oxLDLs) induce further oxidative reactions in FH patients, which contributes to the development of atherosclerosis and advanced cardiovascular events in these patients. This study aimed to investigate the association of oxidant/antioxidant markers with FH. METHODS: This case-control study comprised 18 HoFH, 18 HeFH, and 20 healthy subjects. Oxidant/antioxidant markers including MDA, MPO, thiol, nitric oxide (NO), myeloperoxidase (MPO), glutathione peroxidase (GPx), SOD, and CAT were assessed by colorimetric methods. Prooxidant-antioxidant balance was also measured by pro-oxidant antioxidant balance (PAB) assay. RESULTS: The levels of MDA ( < 0.001), MPO activity ( < 0.001), thiol ( < 0.001), NO ( < 0.01), and PAB ( < 0.001) were notably higher in HoFH group in comparison with healthy subjects. HeFH group also showed significantly higher levels of thiol ( < 0.001) and PAB ( < 0.001) when compared to healthy subjects. Elevated levels of MDA ( < 0.001) and PAB ( < 0.001) were also observed in HoFH relative to HeFH. No significant differences were found between the studied groups in the case of antioxidant enzyme activities. The results of binary logistic regression showed that PAB (OR: 0.979; = 0.033), and MDA (OR: 0.996; = 0.018) levels were inversely associated with HoFH, although, after adjustment for age and LDL-C levels, these associations were diminished. CONCLUSION: Several oxidant/antioxidant differences were found between FH patients and healthy individuals as well as between HoFH and HeFH patients. These differences might be strongly dependent on plasma LDL-C levels.
J Clin Med. 2021-12-14
Oxid Med Cell Longev. 2022
J Atheroscler Thromb. 2021-7-1
J Am Coll Cardiol. 2020-2-18
Arch Med Sci. 2022-5-29
Noncoding RNA Res. 2024-3-8
Trends Cardiovasc Med. 2021-5
Cardiol Res Pract. 2018-6-12
Kardiol Pol. 2018-3-14
J Cell Physiol. 2018-3-7
Prog Lipid Res. 2017-5-12
Can Fam Physician. 2016-1
Oxid Med Cell Longev. 2016